Evaluation of the Usefulness of a Center Specialized in the Standardized Management of Rheumatoid Arthritis: The COMEDRA Trial
Patients with a stable definite Rheumatoid Arthritis will be invited by their
rheumatologists to participate at this study in 20 centers in France. After written informed
consent will be obtained, the patients will be randomized in two arms:
- comorbidities
- auto-DAS The patients will be seen again in the same center six months later in order
to collect the outcome measures.
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label
Comorbidities treatment
Number of actions initiated I order to treat or prevent Rheumatoid Arthritis comorbidities
6 months later
No
Maxime Dougados, MD, PhD
Principal Investigator
Assistance Publique - Hôpitaux de Paris
France: Ministry of Health
P100113
NCT01315652
March 2011
September 2012
Name | Location |
---|